Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2–4 Weeks of Life: Clinical Report

作者：Sanjiv Harpavat, Susan W. Aucott, Saul J. Karpen, Benjamin L. Shneider, Kasper Wang, and the SECTION ON GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION, Mitchell B. Cohen, David Brumbaugh, Jennifer L. Dotson, Sanjiv Harpavat, Jenifer R. Lightdale, Daniel Mallon, Maria Oliva‐Hemker, Eric C. Eichenwald, Charletta Guillory, Ivan Hand, Mark L. Hudak, David A. Kaufman, Camilia R. Martin, Margaret Parker, Arun Kumar Pramanik, Kelly C. Wade, SECTION ON SURGERY, Andrew M. Davidoff, Elizabeth A. Beierle, Gail E. Besner, Marybeth Browne, Cynthia D. Downard, Kenneth W. Gow, Saleem Islam, Danielle Walsh · 发表于：PEDIATRICS · 年份：2025 · DOI：10.1542/peds.2024-070077 · 被引用次数：10 · 研究领域：Pediatric Hepatobiliary Diseases and Treatments、Congenital Anomalies and Fetal Surgery、Gallbladder and Bile Duct Disorders

This report helps pediatric primary care providers quickly identify infants with biliary atresia, which has the potential to improve outcomes and reduce need for liver transplant. The strategy is intended to be used between 2 and 4 weeks of life at the "By 1 month" well-child visit in the Bright Futures/American Academy of Pediatrics "Recommendations for Preventive Pediatric Health Care." The strategy involves examining every infant's eye color, stool color, and prior laboratory results to determine whether measurement of a direct or conjugated bilirubin level is warranted.